全球心臟封堵器市场规模、份额、趋势和成长分析报告（2026-2034年）

预计心臟闭合装置市场将从 2025 年的 51.2 亿美元成长到 2034 年的 199 亿美元，2026 年至 2034 年的复合年增长率为 16.29%。

由于心血管疾病仍是全球主要死因之一，全球心臟封堵器设备市场正稳定成长。心房中隔缺损（ASD）和卵圆孔未闭合（PFO）封堵系统等器械因其微创手术优势和改善患者预后而备受关注。人们对结构性心臟疾病的认识不断提高以及早期诊断技术的进步，进一步推动了市场渗透。

成长要素包括设备设计的技术进步、老年人口的成长以及获得先进心臟护理服务的途径增加。微创导管手术可缩短住院时间和復原时间，从而鼓励患者和医疗服务提供者选择封闭式设备。已开发国家优惠的健保报销政策也促进了市场渗透。

随着产品不断创新和临床研究的不断拓展，未来前景十分乐观。随着医疗基础设施的不断完善，新兴市场可望提供盈利的成长机会。由于介入性心臟病学的进步以及患者对微创治疗日益增长的偏好，心臟封堵器械市场将保持稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心臟封堵器市场：依产品划分

• 市场分析、洞察与预测
• 心房中膈缺损症（ASD）封堵装置
• 室间隔缺损（VSD）封堵装置
• 卵圆通畅性闭合装置
• 左心耳封堵装置
• 其他产品

第五章 全球心臟封堵器市场：依材料分类

• 市场分析、洞察与预测
• 基于镍钛诺的装置
• 不銹钢装置
• 其他材料

第六章：全球心臟封堵器市场：依输送方式划分

• 市场分析、洞察与预测
• 经导管输送
• 手术分娩

第七章 全球心臟封堵器市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心（ASC）
• 心臟导管检查室
• 其他最终用户

第八章 全球心臟封堵器市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • AtriCure
  • Biosense Webster
  • Boston Scientific Corporation
  • Cardia
  • Heartstitch
  • Lepu Medical Technology（Beijing）Co. Ltd
  • LifeTech Scientific Corporation
  • Medtronic
  • Occlutech
  • SentreHEART
  • Starway Medical Technology
  • WL Gore & Associates

The Heart Closure Devices Market size is expected to reach USD 19.90 Billion in 2034 from USD 5.12 Billion (2025) growing at a CAGR of 16.29% during 2026-2034.

The Global Heart Closure Devices Market is growing steadily as cardiovascular disorders remain a leading cause of mortality worldwide. Devices such as atrial septal defect (ASD) and patent foramen ovale (PFO) closure systems are gaining traction due to minimally invasive procedures and improved patient outcomes. Increasing awareness and early diagnosis of structural heart defects are further boosting market adoption.

Key growth drivers include technological advancements in device design, rising geriatric populations, and expanding access to advanced cardiac care. Minimally invasive catheter-based procedures reduce hospital stays and recovery times, encouraging both patients and healthcare providers to opt for closure devices. Favorable reimbursement policies in developed economies also support market penetration.

Future prospects appear strong with continuous product innovation and expanding clinical research. Emerging markets are expected to offer lucrative growth opportunities due to improving healthcare infrastructure. As interventional cardiology evolves and patient preference shifts toward less invasive treatments, the heart closure devices market will maintain steady upward momentum.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Atrial Septal Defect (ASD) Closure Devices
• Ventricular Septal Defect (VSD) Closure Devices
• Patent Foramen Ovale (PFO) Closure Devices
• Left Atrial Appendage (LAA) Closure Devices
• Other Products

By Material

• Nitinol-Based Devices
• Stainless Steel Devices
• Other Materials

By Mode of Delivery

• Transcatheter Delivery
• Surgical Delivery

By End Use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cardiac Catheterization Laboratories
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, AtriCure, Biosense Webster, Boston Scientific Corporation, Cardia, Heartstitch, Lepu Medical Technology Beijing Co Ltd, LifeTech Scientific Corporation, Medtronic, Occlutech, SentreHEART, Starway Medical Technology, W L Gore Associates
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART CLOSURE DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Atrial Septal Defect (ASD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Ventricular Septal Defect (VSD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Patent Foramen Ovale (PFO) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Left Atrial Appendage (LAA) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEART CLOSURE DEVICES MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Nitinol-Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Stainless Steel Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEART CLOSURE DEVICES MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. Transcatheter Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Surgical Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEART CLOSURE DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEART CLOSURE DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Material
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Material
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Material
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Material
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Material
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEART CLOSURE DEVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories
  • 10.2.2 AtriCure
  • 10.2.3 Biosense Webster
  • 10.2.4 Boston Scientific Corporation
  • 10.2.5 Cardia
  • 10.2.6 Heartstitch
  • 10.2.7 Lepu Medical Technology (Beijing) Co. Ltd
  • 10.2.8 LifeTech Scientific Corporation
  • 10.2.9 Medtronic
  • 10.2.10 Occlutech
  • 10.2.11 SentreHEART
  • 10.2.12 Starway Medical Technology
  • 10.2.13 W. L. Gore & Associates